Table 5

Associations between maternal genotypic scores and atopy, asthma, FEV1, FVC and FEF25-75 in the offspring of women without iron supplementation in late pregnancy

OR or β*† (95% CI)
Iron scoreFerritin scoreTransferrin scoreTransferrin saturation score
Atopy (n=2208)
 Per SD increase1.08 (0.97 to 1.19)1.06 (0.95 to 1.17)0.97 (0.88 to 1.07)1.05 (0.95 to 1.17)
 P for trend0.150.280.560.31
Asthma (n=2787)
 Per SD increase1.09 (0.97 to 1.22)0.98 (0.88 to 1.10)1.00 (0.90 to 1.12)1.08 (0.96 to 1.21)
 P for trend0.150.750.950.20
FEV1 (n=2300)
 Per SD increase−0.04 (−0.08 to 0.00)−0.02 (−0.06 to 0.02)−0.03 (−0.07 to 0.01)−0.05 (−0.09 to −0.01)
 P for trend0.070.380.130.03
FVC (n=2336)
 Per SD increase−0.03 (−0.07 to 0.01)−0.01 (−0.05 to 0.03)−0.03 (−0.07 to 0.01)−0.04 (−0.08 to 0.00)
 P for trend0.120.720.140.04
FEF25-75 (n=2336)
 Per SD increase−0.02 (−0.06 to 0.02)−0.02 (−0.06 to 0.02)−0.02 (−0.06 to 0.02)−0.02 (−0.06 to 0.02)
 P for trend0.350.390.360.28
  • *OR for asthma and atopy; difference in age, height and gender-adjusted SD units (β) for FEV1, FVC and FEF25-75.

  • †Adjusted for population substructure.

  • FEF25-75, maximal mid-expiratory flow; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.